Human SERCA2a levels correlate inversely with age in senescent human myocardium

Journal of the American College of Cardiology

Volumn 32, Issue 2, 1998, Pages 458-467

  Cain, Brian S ^a   Meldrum, Daniel R ^a   Joo, Kyung S ^a   Wang, Ju Feng ^a   Meng, Xianzhong ^a   Cleveland Jr , Joseph C ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM);

AGING; ARTICLE; CALCIUM TRANSPORT; DIAGNOSTIC VALUE; ENZYME ASSAY; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; SARCOPLASMIC RETICULUM; TISSUE DISTRIBUTION;

ADULT; AGED; AGING; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CALSEQUESTRIN; COHORT STUDIES; CYTOSOL; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART ATRIA; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; SARCOPLASMIC RETICULUM;

EID: 0032145716     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00233-2     Document Type: Article

References (73)

1. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1992;205-211.
2. Tresch D.D., McGough M.F. Heart failure with normal systolic function a common disorder in older people . J Am Geriatr Soc. 43:1995;1035-1042.
3. Tardiff J.C., Rouleau J.L. Diastolic dysfunction. Can J Cardiol. 12:1996;389-398.
4. Taffet G.E., Hartley C.J., Wen X., et al. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am J Physiol. 270:1996;H2204-H2209.
5. Abete P., Cioppa A., Ferrara P., Caccese P., Ferrara N., Rengo F. Reduced aerobic metabolic efficiency in postischemic myocardium dysfunction in rats role of aging . Gerontology. 41:1995;187-194.
6. Besse S., Assayag P., Delcayre C., et al. Normal and hypertrophied senescent rat heart mechanical and molecular characteristics . Am J Physiol. 265:1993;H183-H190.
7. Hanno O., Bogdanov K.Y., Sakai M., et al. Reduced threshold for myocardial cell calcium intolerance in the rat heart with aging. Am J Physiol. 269:1995;H1607-H1612.
8. Calderone C.A., Krukenkamp I.B., Burns P.G., et al. Blood cardioplegia in the senescent heart. J Thorac Cardiovasc Surg. 109:1995;269-274.
9. Zuccala G., Sgadari A., Cocchi A., Bernabei R., Carbonin P. Effect of age and pathology on left ventricular diastolic function the diagnostic yield of Doppler echocardiography . J Gerontol Biol Sci Med Sci. 50:1995;M78-M82.
10. Zuccala G., Cocchi A., Lattanzio F., Bernabei R., Carbonin P.U. Effect of age on left atrial function in patients with coronary artery disease. Cardiology. 85:1994;8-13.
11. Villari B., Vassali G., Schnieder J., Chiarello M., Hess O.M. Age dependency of left ventricular diastolic dysfunction in pressure overload hypertrophy. J Am Coll Cardiol. 29:1997;181-186.
12. Meldrum D.R., Cleveland J.C., Sheridan B.C., Rowland R.T., Banerjee A., Harken A.H. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg. 61:1996;1273-1280.
13. Meldrum D.R., Cleveland J.C., Sheridan B.C., Rowland R.T., Banerjee A., Harken A.H. Cardiac preconditioning with calcium clinically accessible myocardial protection . J Thorac Cardiovasc Surg. 112:1996;778-786.
14. 2+ induced cardioadaptation to ischemia-reperfusion injury. Am J Physiol. 271:1996;R1718-R1726.
15. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92:1995;778-784.
16. Cain BS, Harken AH: Surgical treatment of diastolic dysfunction. J Cardiovasc Surg 1998;In Press.
17. Cain BS, Meldrum DR, Joo KS, Davis RJ, Harken AH. Diastolic hibernation masquerading as constrictive pericarditis. J Cardiovasc Surg 1998;In Press.
18. Cain BS, Meldrum DR, Dinarello CA, et al. Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion. J Surg Res 1998;In Press.
19. Cain BS, Meldrum DR, Meng X, et al. Therapeutic anti-dysrhythmic and functional protection in human atria. J Surg Res 1998;In Press.
20. Cain BS, Meldrum DR, Meng X, et al. Calcium preconditioning in human myocardium. Ann Thorac Surg 1998;In Press.
21. Cleveland J.C., Meldrum D.R., Rowland R.T., et al. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery. 120:1996;345-353.
22. Cleveland J.C., Wollmering M.M., Meldrum D.R., et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol. 271:1996;H1786-H1794.
23. Cleveland J.C., Meldrum D.R., Cain B.S., Banerjee A., Harken A.H. Oral sulfonylurea agents prevent ischemic preconditioning in human myocardium. Circulation. 96:1997;29-32.
24. 1 adrenoceptors and protein kinase C. Am J Physiol. 273:1997;H902-H908.
25. + channel. J Mol Cell Cardiol. 29:1997;175-182.
26. + channel? Circ Res. 77:1995;1030-1035.
27. Yellon D.M., Alkhulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
28. Walker D.M., Walker J.M., Pugsley W.B., Pattison C.W., Yellon D.M. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 27:1995;1349-1357.
29. Koiwa Y., Honda H., Takagi T., et al. Modification of human left ventricular relaxation by small-amplitude, phase-controlled mechanical vibration on the chest wall. Circulation. 95:1997;156-162.
30. Rockman H.A., Hamilton R.A., Jones L.R., et al. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest. 97:1996;1618-1623.
31. Weiss J.L., Frederickson J.W., Weisfeldt M.L. Hemodynamic determinants of the time course of fall in canine left ventricular pressure. J Clin Invest. 58:1976;751-760.
32. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680-685.
34. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem. 272:1997;15872-15880.
35. Kimura Y., Kurzydlowski K., Tada M., MacLennan D.H. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem. 272:1997;15061-15064.
36. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 65:1989;1141-1144.
37. Melchoir T., Gadsboll N., Hildebrandt P., Kober L., Torp-Petersen C. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving and acute myocardial infarction. Diabet Med. 13:1996;450-456.
38. Kay G.L., Sun G.W., Aoki A., Prejean C.A.J. Influence of ejection fraction on hospital mortality, morbidity, and costs for CABG. Ann Thorac Surg. 60:1995;1640-1650.
39. Nath S., DeLacey W.A., Haines D.E., et al. Use of a regional wall motion score to enhance risk stratification of patient receiving an implantable cardioverter-defibrillator. J Am Coll Cardiol. 22:1993;1093-1099.
40. Funk M., Pooley-Richards R.L. Predicting hospital mortality in patients with acute myocardial infarction. Am J Crit Care. 3:1994;168-176.
41. Grossman W. Diastolic dysfunction and congestive heart failure. Circulation. 81:1990;1-7.
42. Grossman W. Diastolic dysfunction in congestive heart failure. New Engl J Med. 325:1991;1557-1564.
43. Litwin S.E., Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol. 22:1993;49A-55A.
44. O'Leary J.P. The Physiologic Basis of Surgery. 2nd ed. 1996;349 Williams and Wilkins, Baltimore.
45. Banerjee A., Winter-Locke C., Rogers K., et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ Res. 73:1993;656-670.
46. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
47. Grosso M.A., Brown J.M., Muluin D., et al. Xanthine oxidase derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J Surg Res. 46:1989;355-360.
48. Steenbergen C., Fralix T.A., Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol. 88:1993;456-470.
49. Shen A.C., Jennings R.B. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol. 67:1972;417-440.
50. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 245:1983;C1-C14.
51. 2+ channels and ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci (USA). 92:1995;121-125.
52. Hatem S.N., Benardeau A., Rucker-Martin C., et al. Different compartments of sarcoplasmic reticulum participate in the excitation-contraction coupling process in human atrial myocytes. Circ Res. 80:1997;345-353.
53. Tate C.A., Hyek M.F., Taffet G.E. Mechanisms for the responses of cardiac muscle to physical activity in old age. Med Sci Sports Excerc. 26:1994;561-567.
54. 2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol. 261:1991;23-26.
55. Arai M., Alpert N.R., Maclennan D.H., Barton P., Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium . Circ Res. 72:1993;463-469.
56. Arai M., Matsui H., Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 74:1994;555-564.
57. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
58. Swynghedauw B., Besse S., Assayag P., et al. Molecular and cellular biology of the senescent hypertrophied and failing heart. Am J Cardiol. 76:1995;2D-7D.
59. Schwartz K., Carrier L., Lompre A.M., Mercadier J.J., Bohler K.R. Contractile proteins and sarcoplasmic reticulum calcium-ATPase gene expression in the hypertrophied and failing heart. Basic Res Cardiol. 87:1992;284-290.
60. Schwartz K., Chassagne C., Boheler K.R. The molecular biology of heart failure. J Am Coll Cardiol. 22:1993;30A-33A.
61. Liu X., Engelman R.M., Wei Z., et al. Postischemic deterioration of sarcoplasmic reticulum warm versus cold blood cardioplegia . Ann Thorac Surg. 56:1993;1154-1159.
62. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res. 66:1990;554-564.
63. dosRemedios C.G., Berry D.A., Carter L.K., et al. Different electrophoretic techniques produce conflicting data in the analysis of myocardial samples for dilated cardiomyopathy patients protein levels do not necessarily reflect mRNA levels . Electrophoresis. 17:1996;235-238.
64. 2+-ATPase and phospholamban mRNAs during rat heart development. Circ Res. 76:1995;616-625.
65. 2+-ATPase with phospholamban in phospholipid vesicles. J Biol Chem. 265:1990;1702-1709.
66. MacLennan D.H., Wong P.T.S. Isolation of a calcium sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci (USA). 68:1971;1231-1235.
67. Lytton J., MacLennan D.H. Sarcoplasmic reticulum. Fozzard H.A., Hennings R.B., Haber E., Katz A.M. The Heart and Cardiovascular System. 1991;1203-1222 Raven Press, Inc, New York.
68. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 90:1992;927-935.
69. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
70. Hajjar R.J., Kang J.X., Gwathmey J.K., Rosenweig A. Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation. 95:1997;423-429.
71. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest. 100:1997;380-389.
72. Rousseau M.F., Veriter C., Detry J.M., Brasseur L., Pouleur H. Impaired early left ventricular relaxation in coronary artery disease effects of intracoronary nifedipine . Circulation. 62:1980;764-772.
73. Matsubara H., Takaki M., Yasuhara S., Araki J., Suga H. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better alternative to exponential time constant. Circulation. 92:1995;2318-2326.